Type 1 Diabetes Extension Study
Conditions
Type 1 Diabetes Mellitus · T1DM · T1D
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCSF School of Medicine, San Francisco, California, United States
Contact: Principal Investigator (Stephen Gitelman, MD)Stanford University, Stanford, California, United States
Contact: Principal Investigator (Darrell Wilson, MD)University of Colorado School of Medicine: Barbara Davis Center for Diabetes, Aurora, Colorado, United States
Contact: Principal Investigator (Peter Gottlieb, MD)Yale University, New Haven, Connecticut, United States
Emory University, Atlanta, Georgia, United States
Indiana University Riley Hospital for Children, Indianapolis, Indiana, United States
Contact: Principal Investigator (Linda DiMeglio, MD, MPH)University of Iowa Health Care Division of Pediatric Endocrinology, Iowa City, Iowa, United States
Contact: Principal Investigator (Michael Tansey, MD)Joslin Diabetes Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Jason Gaglia, MD)University of Minnesota, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Antoinette Moran, MD)Children's Mercy Hospital, Kansas City, Missouri, United States
Sanford Research, Sioux Falls, South Dakota, United States
Benaroya Research Institute, Seattle, Washington, United States
Contact: Principal Investigator (Sandra Lord, MD)
Study leads
Linda A. DiMeglio, MD, MPH,MA
Study Chair
Riley Hospital for Children at Indiana University Health